Category: Uncategorized

What’s All The Buzz? BioViva’s Platform For Expedited Drug Development

28 February 2018

Aging is the root cause of the diseases of old age, and this disease burden causes an immense amount of suffering to individuals and...

Read more

Gene Therapy using anti-inflammatory cytokines promising against MS

30 January 2018

BioViva scientist Ali Fallah and his team work on novel gene therapy using anti-inflammatory cytokines and show that these can be a promising approach...

Read more

Source of stem cells that are easily available and raise no ethical concerns

24 January 2018

Research by BioViva scientist Ali Fallah: ” In this study, we describe an efficient approach for stable knockdown of adenosine kinase (ADK) using lentiviral...

Read more

BioViva Supports Patient Advocacy For Gene Therapy

30 March 2017

“Patient advocates are the driving force behind the development of many new drugs and amendments to medical regulations. It is the common man and...

Read more

Dual Gene Therapy Has Beneficial Effects On Blood Biomarkers And Muscle Composition

2 March 2017

In April 2016 BioViva USA Inc. published a press release stating that Elizabeth Parrish, CEO, had experienced telomere lengthening in her leukocytes, as a...

Read more

One Year Anniversary Of Bioviva’s Gene Therapy Against Human Aging

2 March 2017

It has officially been one year since I volunteered to take the first gene therapy to treat biological aging. It has been an amazing...

Read more

Gene Therapy For Sickle Cell Disease Passes Key Preclinical Test

7 September 2016

A precision-engineered gene therapy virus, inserted into blood stem cells that are then transplanted, markedly reduced sickle-induced red-cell damage in mice with sickle cell...

Read more

Bioviva, Gene Therapy And Blockchain Merges In Russia

2 September 2016

During June 20th to the 23rd, founder and CEO of BioViva USA Inc, Elizabeth Parrish visited Moscow at the invitation of board member of...

Read more

First Patent Application For Dual Gene Therapy Targeting The Aging Process

20 June 2016

BioViva USA Inc. files for patent for dual gene therapy to restore telomere attrition and muscle degradation caused by aging In 2015 the CEO...

Read more